Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Hodgkin's Disease|Breast Cancer
Interventions: DRUG: Tamoxifen
Sponsor: Dana-Farber Cancer Institute
Collaborators: Brigham and Women's Hospital|Massachusetts General Hospital|AstraZeneca